Sage Therapeutics Ratios and Metrics

Market cap in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	10,417	12,366	15,733	-	-
Market Cap Growth	-38.52%	-21.40%	-	-	-
Enterprise Value	10,152	12,047	14,969	-	-
Last Close Price	179.60	213.20	268.78	-	-
PE Ratio	119.19	1246.51	33.80	-	-
PS Ratio	6.27	6.74	9.56	-	-
PB Ratio	5.29	6.71	7.92	-	-
P/TBV Ratio	5.30	6.71	7.94	-	-
P/FCF Ratio	-	32.58	-	-	-
P/OCF Ratio	193.67	24.39	-	-	-
EV/Sales Ratio	6.11	6.57	9.09	-	-
EV/EBITDA Ratio	46.73	53.16	32.12	-	-
EV/EBIT Ratio	52.81	57.54	33.35	-	-
EV/FCF Ratio	-120.23	31.74	-	-	-
Debt / Equity Ratio	0.19	0.18	0.01	0.01	0.08
Debt / EBITDA Ratio	1.81	1.39	0.04	0.03	0.12
Debt / FCF Ratio	-	0.89	-	0.03	0.23
Asset Turnover	0.60	0.60	0.76	1.19	-
Inventory Turnover	1.02	1.24	1.43	2.68	-
Quick Ratio	0.83	1.08	1.56	2.08	1.33
Current Ratio	2.33	2.53	2.71	3.29	2.49
Return on Equity (ROE)	5.06%	0.52%	33.64%	22.87%	-
Return on Assets (ROA)	4.15%	4.31%	12.87%	17.88%	-
Return on Capital (ROIC)	5.88%	6.25%	20.09%	27.12%	-
Return on Capital Employed (ROCE)	8.90%	10.80%	21.00%	25.80%	55.20%
Earnings Yield	0.84%	0.08%	2.96%	-	-
FCF Yield	-0.81%	3.07%	-0.93%	-	-
Payout Ratio	175.25%	1543.98%	29.87%	-	-
Buyback Yield / Dilution	-0.61%	-1.03%	-34.58%	-326.57%	-
Total Shareholder Return	0.66%	-1.03%	-34.58%	-326.57%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.